Stockscreener 앱 받기
19.96
0.35%
-0.07
시간 외 거래:
19.96
전일 마감가:
$20.03
열려 있는:
$19.9
하루 거래량:
773.75K
Relative Volume:
0.61
시가총액:
$1.14B
수익:
$322.02M
순이익/손실:
$-102.47M
주가수익비율:
-10.91
EPS:
-1.8295
순현금흐름:
$-80.57M
1주 성능:
+13.60%
1개월 성능:
+10.34%
6개월 성능:
-17.66%
1년 성능:
-42.35%
1일 변동 폭
$18.75
$20.12
1주일 범위
$17.53
$20.12
52주 변동 폭
$16.66
$38.11
Procept Biorobotics Corp Stock (PRCT) Company Profile
명칭
Procept Biorobotics Corp
전화
(650) 232-9832
주소
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT vs ABT, MDT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
19.96 | 1.14B | 322.02M | -102.47M | -80.57M | -1.8295 |
ABT
Abbott Laboratories
|
103.70 | 179.44B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
95.41 | 122.04B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.15 | 117.81B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.69 | 66.22B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.07 | 51.34B | 6.30B | 1.07B | 1.09B | 1.8406 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-10-07 | 개시 | Barclays | Overweight |
| 2026-08-05 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2026-08-05 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2026-07-28 | 다운그레이드 | UBS | Buy → Neutral |
| 2026-07-06 | 다운그레이드 | Truist | Buy → Hold |
| 2026-06-24 | 개시 | Evercore ISI | Outperform |
| 2026-06-11 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2026-03-06 | 개시 | Robert W. Baird | Neutral |
| 2026-02-26 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2026-02-26 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-12-12 | 개시 | UBS | Buy |
| 2025-12-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-09-02 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-07-09 | 개시 | Stephens | Overweight |
| 2025-07-07 | 개시 | Oppenheimer | Perform |
| 2024-12-02 | 개시 | Morgan Stanley | Overweight |
| 2024-11-14 | 개시 | Jefferies | Hold |
| 2023-08-11 | 개시 | Piper Sandler | Overweight |
| 2023-05-31 | 개시 | William Blair | Outperform |
| 2022-10-31 | 개시 | BTIG Research | Neutral |
| 2022-10-25 | 개시 | Truist | Buy |
| 2022-09-02 | 개시 | Wells Fargo | Overweight |
| 2022-07-15 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | 개시 | B. Riley Securities | Buy |
| 2021-10-11 | 개시 | BofA Securities | Buy |
| 2021-10-11 | 개시 | Cowen | Outperform |
| 2021-10-11 | 개시 | Goldman | Neutral |
| 2021-10-11 | 개시 | Guggenheim | Buy |
| 2021-10-11 | 개시 | SVB Leerink | Outperform |
모두보기
Procept Biorobotics Corp 주식(PRCT)의 최신 뉴스
A director receives rights to 7,727 shares and options on 12,191 at PROCEPT BioRobotics (PRCT). - Stock Titan
LAWSUIT ALERT: Investors who lost money with PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares should contact the Shareholders Foundation - GlobeNewswire Inc.
Important Notice to Long-Term Shareholders of Doximity, Inc. (NYSE: DOCS); GoDaddy Inc. (NYSE: GDDY); Planet Fitness, Inc. (NYSE: PLNT); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Office is Investigating Claims on Your Behalf - GlobeNewswire Inc.
Kaplan Fox Continues to Alert Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to a Class Action Deadline on September 22, 2026 - theglobeandmail.com
PRCT Deadline: PRCT Investors with Losses in Excess of $100K Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit - AOL.ca
Deadline Alert: PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit - GlobeNewswire Inc.
PRCT Deadline: Rosen Law Firm Urges PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - Business Wire
Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Seeking Recovery to Contact the Firm Before September 22, 2026 - GlobeNewswire Inc.
INVESTOR DEADLINE: PROCEPT BioRobotics Corporation (PRCT) Investors with Substantial Losses Have Opportunity to Lead the PROCEPT Class Action Lawsuit Before September 22, 2026 - GlobeNewswire Inc.
PROCEPT DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages PROCEPT BioRobotics Corporation Investors to Secure Counsel Before Important September 22 Deadline in Securities Class Action – PRCT - GlobeNewswire Inc.
ROSEN, A LONGSTANDING FIRM, Encourages Doximity, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – DOCS - GlobeNewswire Inc.
DNOW DEADLINE: ROSEN, A LONGSTANDING FIRM, Encourages DNOW Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – DNOW - GlobeNewswire Inc.
WIX.COM DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Wix.com Ltd. Investors to Secure Counsel Before Important September 22 Deadline in Securities Class Action – WIX - GlobeNewswire Inc.
Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors to Contact the Firm Before the Lead Plaintiff Deadline on September 22, 2026 - The Globe and Mail
PRCT 4-DAY DEADLINE ALERT: PROCEPT BioRobotics Corporation Invest - The National Law Review
TUESDAY PRCT INVESTOR DEADLINE: PROCEPT BioRobotics Corporation Investors with Substantial Losses Have Opportunity to Lead the PROCEPT Class Action Lawsuit - PR Newswire
Bragar Eagel & Squire, P.C Urges PROCEPT BioRobotics - GlobeNewswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
PROCEPT DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR - GlobeNewswire
PROCEPT DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR - GlobeNewswire
How Discounting Lawsuits At PROCEPT BioRobotics Stock Have Changed Its Investment Story - simplywall.st
PROCEPT DEADLINE: ROSEN, HIGHLY REGARDED TRIAL ATTORNEYS, - GlobeNewswire
PRCT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that PROCEPT BioRobotics Corporation Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock DeclineInvestors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - PR Newswire
Kaplan Fox Encourages Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to Contact the Firm Before Lead Plaintiff Deadline on September 22, 2026 - Barchart.com
PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
PRCT DEADLINE NOTICE: PROCEPT BioRobotics Corporation Investors Encouraged to Contact Kirby McInerney LLP By September 22, 2026 - ACCESS Newswire
PROCEPT BioRobotics Corporation (PRCT) Investors: September 22, 2026 Filing Deadline in Securities Class ActionContact Lieff Cabraser - ACCESS Newswire
PRCT Deadline: PRCT Investors with Losses in Excess of $100K Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit - Laurel Leader-Call
Procept BioRobotics EVP Alaleh Nouri sells $6,223 in PRCT stock By Investing.com - Investing.com Nigeria
Procept BioRobotics EVP Alaleh Nouri sells $6,223 in PRCT stock By Investing.com - Investing.com Australia
Kaplan Fox Encourages Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to Contact the Firm to Learn About Their Legal Rights - theglobeandmail.com
Kaplan Fox Encourages Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to Contact the Firm to Learn About Their Legal Rights - theglobeandmail.com
Kaplan Fox Encourages Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to Contact the Firm to Learn About Their Legal Rights - Barchart.com
PROCEPT BioRobotics CFO Kevin Waters Sells 373 Shares in Tax Withholding Transaction - kalkinemedia.com
PROCEPT BioRobotics EVP Alaleh Nouri Sells 297 Shares for Tax Withholding on RSU Vesting - kalkinemedia.com
Procept BioRobotics EVP Alaleh Nouri sells $6,223 in PRCT stock - investing.com
Procept BioRobotics EVP Alaleh Nouri sells $6,223 in PRCT stock By Investing.com - Investing.com India
Procept BioRobotics EVP Alaleh Nouri sells $6,223 in PRCT stock By Investing.com - Investing.com UK
Procept BioRobotics EVP Alaleh Nouri sells $6,223 in PRCT stock - Investing.com
Tax-withholding share sale for PROCEPT BioRobotics (PRCT) CTO - Stock Titan
Tax-withholding sale trims PROCEPT BioRobotics (PRCT) CFO stake - Stock Titan
Kaplan Fox Class Action Reminder: PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Lead Plaintiff Deadline is September 22, 2026 - NewMediaWire
PRCT 12-DAY DEADLINE ALERT: PROCEPT BioRobotics Corporation Investors Alerted to September 22, 2026 Lead Plaintiff Deadline in Class Action Lawsuit - PR Newswire
DEADLINE ALERT for WIX, PRCT, and PNR: The Law Offices of - GlobeNewswire
PROCEPT BIOROBOTICS CORPORATION INVESTORS WITH LOSSES HAVE - GlobeNewswire
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit with SBS Law - GlobeNewswire
PRCT Deadline Alert: SueWallSt Reminds PROCEPT BIOROBOTICS CORPORATION (PRCT) Investors of Securities Class Action Deadline on September 22, 2026 - PR Newswire
Kaplan Fox Class Action Reminder: PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Lead Plaintiff Deadline is September 22, 2026 - The Globe and Mail
Procept Biorobotics Corp (PRCT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Procept Biorobotics Corp 주식 (PRCT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Waters Kevin | EVP, CFO |
Sep 09 '26 |
Sale |
20.95 |
373 |
7,815 |
180,355 |
| Templin Barry L | EVP, Chief Technology Officer |
Sep 09 '26 |
Sale |
20.95 |
373 |
7,815 |
94,826 |
| Nouri Alaleh | Officer |
Sep 09 '26 |
Proposed Sale |
20.95 |
297 |
6,223 |
0 |
| Templin Barry L | Officer |
Sep 09 '26 |
Proposed Sale |
20.95 |
373 |
7,816 |
0 |
| Waters Kevin | Officer |
Sep 09 '26 |
Proposed Sale |
20.95 |
373 |
7,816 |
0 |
| Wood Larry L | President, CEO |
Aug 07 '26 |
Buy |
20.85 |
23,900 |
498,315 |
23,900 |
| Nouri Alaleh | EVP, CLO, CORP. SEC. |
Jun 08 '26 |
Sale |
28.48 |
285 |
8,117 |
105,069 |
| Waters Kevin | EVP, CFO |
Jun 08 '26 |
Sale |
28.48 |
357 |
10,167 |
151,201 |
| Templin Barry L | EVP, Chief Technology Officer |
Jun 08 '26 |
Sale |
28.48 |
358 |
10,195 |
68,953 |
| Nouri Alaleh | Officer |
Jun 08 '26 |
Proposed Sale |
28.48 |
285 |
8,117 |
0 |
2.80%
7.07%
자본화:
|
볼륨(24시간):